查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944396

全球胸廓出口症候群市场：按给药途径、技术/作用机制、药物类别、产品类型、适应症、最终用户、国家和地区划分－产业分析、市场规模、份额和预测（2025-2032）

Thoracic Outlet Syndrome Market, By Route of Administration, By Technology/Mode of Action, By Drug Class, By Product Type, By Application, By End-User, By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 389 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年胸廓出口症候群 (TOS) 市场规模价值为 2.2119 亿美元，从 2025 年到 2032 年将以 5.50% 的复合年增长率成长。

胸廓出口症候群 (TOS) 市场涵盖诊断服务、治疗性介入以及用于治疗颈肩部神经、静脉和动脉受压的手术方案。重复性劳损和与久坐生活方式及体力劳动强度大的职业相关的姿势相关疾病的增加，正在推动市场成长。一个显着的趋势是，在先进影像和神经监测技术的支持下，微创减压手术正逐渐兴起。然而，人们对 TOS 的认知度低以及误诊率高仍然是主要障碍。儘管存在这些挑战，但扩大復健计划、实施符合人体工学的解决方案以及加强临床医生培训，为改善早期诊断、提高治疗效果和促进市场整体扩张提供了重要机会。

胸廓出口症候群市场动态

药物疗法的日益普及将推动市场成长

由于越来越多的患者选择药物治疗作为手术介入前的首选治疗方案，胸廓出口症候群市场正在成长。医生越来越多地使用抗发炎药物、肌肉鬆弛剂和止痛药等药物来缓解症状并改善患者预后，尤其是在神经源性胸廓出口症候群的病例中。这种保守治疗方法减少了侵入性手术的需求，缩短了恢復时间，并有助于提高患者的长期依从性。正在进行的临床研究进一步强化了这一趋势，这些研究比较了保守治疗和手术治疗的效果，并证实了非手术治疗方案的有效性。例如，马斯垂克大学2022年7月的一项研究比较了神经源性胸廓出口症候群患者的手术治疗和持续保守治疗，结果显示，50名患者最初接受了保守治疗，这反映了药物治疗的日益普及。

胸廓出口症候群市场：細項分析

全球胸廓出口症候群市场按给药途径、技术/作用机制、药物类别/产品类型、适应症、最终用户和地区进行细分。

口服给药途径占主导地位。截至2024年，口服给药途径占总给药途径的绝大部分。随着胸廓出口症候群（TOS）病例的增加，尤其是神经源性TOS病例的增加，由于口服药物的便利性和可及性，其使用量也不断增加。因此，口服药物已成为热门选择，促进了该领域的成长。根据梅奥诊所2023年发布的《胸廓出口症候群治疗指南》，非类固醇消炎剂（NSAIDs），如Ibuprofen和萘普生，是常用的口服处方药，可减轻患者的发炎和疼痛。

神经源性胸廓出口症候群（TOS）细分市场仍然是最大的市场份额贡献者，这主要得益于其高发病率和不断增长的病例数。神经源性TOS是该疾病最常见的类型，因此对诊断服务和治疗性介入的需求不断增加。根据美国国家医学图书馆（2022年10月）的数据，神经源性TOS的年发生率估计为每10万人2-3例，盛行率约为每10万人10例。此亚型约占所有TOS病例的90-95%，凸显了其在塑造市场动态的主导地位。

胸廓出口症候群市场—区域分析

北美凭藉其高度发展的诊断中心体系、现代影像诊断技术的积极应用以及众多多专科中心，占据了显着的市场份额。医生、物理治疗师和外科医生临床意识的提高，使得神经性、静脉性和动脉性胸廓出口症候群（TOS）的早期发现和鑑别成为可能。微创手术技术、全面的復健计画以及完善的健保报销体系，共同确保了病患获得必要的治疗。此外，美国和加拿大的领导企业医疗设备市场和研究机构持续投资于先进的手术器材、电脑诊断和姿势测试技术，进一步巩固了北美在全球市场的主导地位。

美国胸廓出口症候群市场—国家分析

美国预计将引领北美胸廓出口症候群市场，这主要得益于运动员中该综合征发病率的不断上升，以及美国先进的医疗基础设施普及，从而能够及时诊断和有效治疗。强大的临床能力和专业的医疗中心进一步巩固了美国的市场地位。例如，根据美国国立卫生研究院（NIH）2024年10月发布的数据，一项研究旨在确定2010年至2021年美国胸廓出口症候群的住院负担和治疗结果。结果显示，37,174例住院病例中，静脉型胸廓出口症候群占7,397例，动脉型胸廓出口症候群占3,346例，神经型胸廓出口症候群占26,430例。

目录

第一章 胸廓出口症候群市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 胸廓出口症候群的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

4. 胸廓出口症候群市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 胸廓出口症候群市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 胸廓出口症候群市场现状

  • 胸廓出口症候群市场占有率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 胸廓出口症候群市场（依给药途径划分）

  • 概述
    • 细分市场占有率分析：依管理途径
    • 肠外
    • 口服
    • 其他的

8. 依技术/作用机转分類的胸廓出口症候群市场

  • 概述
    • 细分市场占有率分析：依技术/作用机制划分
    • 神经和血管减压装置
    • 物理復健与手法治疗技术
    • 微创手术技术
    • 药物镇痛
    • 影像和诊断方法

9. 胸廓出口症候群药物市场

  • 概述
    • 细分市场占有率分析：依药物类别划分
    • 非类固醇消炎剂（NSAIDs）
    • 抗凝血剂
    • 皮质类固醇
    • 肌肉鬆弛剂
    • 溶栓药物
    • 其他的

第十章 胸廓出口症候群市场（依产品类型划分）

  • 概述
    • 细分市场占有率分析：依产品类型
    • 物理治疗和復健解决方案
      • 神经滑动法
      • 姿势矫正计划
    • 药物治疗
      • 非类固醇消炎剂（NSAIDs）
      • 神经病变疼痛药物
      • 肌肉鬆弛剂
    • 影像诊断和评估工具
      • 多普勒超音波系统
      • MRI/CT影像诊断系统
    • 外科手术器械及设备
      • 第一肋骨切除器械
      • 斜角肌切除器械
    • 辅助/辅助处理设备
      • 疼痛管理装置
      • 矫正器具

第十一章 胸廓出口症候群市场（依应用领域划分）

  • 概述
    • 细分市场占有率分析：按应用
    • 动脉胸廓出口症候群
    • 静脉性胸廓出口症候群
    • 神经源性胸廓出口症候群
    • 混合型/特异性胸廓出口综合征

第十二章 胸廓出口症候群市场（依最终用户划分）

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院及专科医疗中心
    • 物理治疗和復健诊所
    • 门诊手术中心
    • 诊断影像中心
    • 其他最终用户

第十三章 胸廓出口症候群市场：依地区划分

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十四章 主要供应商分析：胸廓出口症候群产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Stryker
    • Globus Medical
    • Becton Dickinson（BD）
    • Smith and Nephew
    • Hologi
    • Zimmer Biomet
    • Cook Medical
    • Abbott
    • B. Braun
    • Teleflex
    • Philips Healthcare
    • Terumo Corporation
    • Medtronic
    • Cardinal Health
    • Boston Scientific
    • CONMED Corporation
    • Johnson &Johnson（DePuy Synthes）
    • Siemens Healthineers
    • GE HealthCare
    • Koninklijke Philips
    • NuVasive
    • Arthrex
    • AngioDynamics
    • Others

第十五章 AnalystView 360度分析

简介目录
Product Code: ANV6021

Thoracic Outlet Syndrome Market size was valued at US$ 221.19 Million in 2024, expanding at a CAGR of 5.50% from 2025 to 2032.

The thoracic outlet syndrome (TOS) market includes diagnostic services, therapeutic interventions, and surgical solutions for treating nerve, vein, or artery compression in the neck and shoulder region. The increasing prevalence of repetitive strain injuries and posture-related disorders associated with sedentary lifestyles and physically demanding occupations is driving market growth. A notable trend is the shift toward minimally invasive decompression procedures, which are aided by advanced imaging and nerve monitoring technologies. However, limited awareness and frequent misdiagnosis of TOS are major barriers. Despite this, expanding rehabilitation programs, implementing ergonomic solutions, and improving clinician training offer significant opportunities to improve early diagnosis, treatment outcomes, and overall market expansion.

Thoracic Outlet Syndrome Market- Market Dynamics

Increasing Adoption of Pharmacologic Management Fuel Market Growth

The thoracic outlet syndrome market is witnessing growth due to the increasing use of pharmacologic management as a primary step before surgical intervention. Physicians are increasingly adopting medications such as anti-inflammatory agents, muscle relaxants, and pain management drugs to relieve symptoms and improve patient outcomes, especially in neurogenic TOS cases. This conservative approach helps reduce the need for invasive procedures, shortens recovery time, and supports better long-term patient compliance. The trend is further strengthened by ongoing clinical studies comparing conservative care with surgery, reinforcing the effectiveness of non-surgical treatment pathways. For instance, a July 2022 study by Maastricht University compared surgery versus continued conservative treatment in neurogenic TOS, where 50 patients initially received conservative therapy, reflecting growing adoption of pharmacologic management.

Thoracic Outlet Syndrome Market- Segmentation Analysis:

The Global Thoracic Outlet Syndrome Market is segmented on the basis of Route of Administration, Technology/Mode of Action, Drug Class, Product Type, Application, End-User, and Region.

The oral segment is in dominant position. In 2024, the oral route of administration accounted for majority of the total. The rising number of cases associated with TOS, particularly neurogenic TOS, is driving an increase in the use of oral drugs due to their convenience and availability. As a result, it became a popular choice and contributed to the segment's growth. According to the Mayo Clinic's 2023 treatment guidelines for Thoracic outlet syndrome, NSAIDs such as ibuprofen or naproxen are commonly prescribed oral medications that help to reduce inflammation and pain in patients.

The neurogenic thoracic outlet syndrome (TOS) segment remains the largest market contributor, driven by its high prevalence and rising case numbers. Neurogenic TOS is the most common form of the condition, resulting in increased demand for diagnostic services and therapeutic interventions. As per data from the National Library of Medicine (October 2022), the annual incidence of neurogenic TOS is estimated at 2-3 cases per 100,000 individuals, with a prevalence of around 10 cases per 100,000 population. This subtype represents approximately 90-95% of all TOS cases, underscoring its dominant role in shaping market dynamics.

Thoracic Outlet Syndrome Market- Geographical Insights

North America holds the significant share in the market, owing to its well-developed diagnostic center system, high use of modern imaging methods, and presence of multidisciplinary specialty centers. Clinical awareness among physicians, physiotherapists, and surgeons has resulted in earlier recognition and differentiation of neurogenic, venous, and arterial TOS. Minimally invasive surgical technologies, extensive rehabilitation programs, and well-developed reimbursement schemes all help patients get the treatment they need. Furthermore, the leaders of the medical device market and research facilities in the United States and Canada are constantly investing in better surgical instruments, computerized diagnostics, and postural examinations, confirming North America's global market dominance.

United States Thoracic Outlet Syndrome Market- Country Insights

The United States is projected to lead the North American thoracic outlet syndrome market, supported by the growing incidence of the condition among athletes and broad access to advanced healthcare infrastructure that enables timely diagnosis and effective treatment. Strong clinical capabilities and specialized care centers further reinforce the country's market position. For example, according to NIH data published in October 2024, a study was conducted to determine the burden of in-hospital admissions and outcomes of thoracic outlet compression syndrome in the United States between 2010 and 2021. It was discovered that of the 37,174 hospitalizations, 7,397 were for venous TOS, 3,346 for arterial TOS, and 26,430 for neurogenic TOS.

Thoracic Outlet Syndrome Market- Competitive Landscape:

The thoracic outlet syndrome (TOS) market is moderately competitive, with medical device manufacturers, surgical solution providers, and specialty healthcare service companies focusing on vascular, neurological, and orthopedic care. Advances in minimally invasive surgical techniques, diagnostic imaging, and postoperative rehabilitation solutions are driving competition. To strengthen their market presence, leading players focus on product innovation, clinical training, and strategic partnerships with hospitals and specialty clinics. Companies are also investing in ergonomic and nerve-monitoring technologies to improve surgical outcomes and lower complications. Medtronic, Stryker, Johnson & Johnson (Ethicon), Abbott and Smith+Nephew are key market players that provide surgical instruments, vascular solutions, and supportive technologies for TOS management.

Recent Developments:

In July 2025, Bristol-Myers Squibb Company and Pfizer Inc. announced a new direct-to-patient option for purchasing Eliquis (apixaban) through Eliquis 360 Support.

In August, 2024, Pfizer Inc. announced that the US Department of Health and Human Services has disclosed the "maximum fair price" (MFP) for ELIQUIS (apixaban).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THORACIC OUTLET SYNDROME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Stryker
  • Globus Medical
  • Becton Dickinson (BD)
  • Smith and Nephew
  • Hologi
  • Zimmer Biomet
  • Cook Medical
  • Abbott
  • B. Braun
  • Teleflex
  • Philips Healthcare
  • Terumo Corporation
  • Medtronic
  • Cardinal Health
  • Boston Scientific
  • CONMED Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Siemens Healthineers
  • GE HealthCare
  • Koninklijke Philips
  • NuVasive
  • Arthrex
  • AngioDynamics
  • Others

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Parenteral
  • Oral
  • Others

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY TECHNOLOGY/MODE OF ACTION- MARKET ANALYSIS, 2019 - 2032

  • Nerve & Vascular Decompression Tools
  • Physical Rehabilitation & Manual Therapy Techniques
  • Minimally Invasive Surgical Technologies
  • Pharmacological Pain Management
  • Imaging & Diagnostic Modalities

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019 - 2032

  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Anticoagulants
  • Corticosteroids
  • Muscle Relaxants
  • Thrombolytics
  • Others

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Physical Therapy & Rehabilitation Solutions
  • Nerve-gliding techniques
  • Postural correction programs
  • Pharmacological Treatments
  • NSAIDs
  • Neuropathic pain medications
  • Muscle relaxants
  • Diagnostic Imaging & Evaluation Tools
  • Doppler ultrasound systems
  • MRI/CT imaging systems
  • Surgical Intervention Tools & Devices
  • First rib resection tools
  • Scalenectomy instruments
  • Supportive & Adjunctive Treatment Devices
  • Pain management devices
  • Orthotic braces

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Arterial Thoracic Outlet Syndrome
  • Venous Thoracic Outlet Syndrome
  • Neurogenic Thoracic Outlet Syndrome
  • Mixed/Non-specified TOS Conditions

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Specialty Care Centers
  • Physiotherapy & Rehabilitation Clinics
  • Outpatient Surgical Centers
  • Diagnostic Imaging Centers
  • Other End-Users

GLOBAL THORACIC OUTLET SYNDROME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Thoracic Outlet Syndrome Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Thoracic Outlet Syndrome Market Snippet by Route of Administration
    • 2.1.2. Thoracic Outlet Syndrome Market Snippet by Technology/Mode of Action
    • 2.1.3. Thoracic Outlet Syndrome Market Snippet by Drug Class
    • 2.1.4. Thoracic Outlet Syndrome Market Snippet by Product Type
    • 2.1.5. Thoracic Outlet Syndrome Market Snippet by Application
    • 2.1.6. Thoracic Outlet Syndrome Market Snippet by End-User
    • 2.1.7. Thoracic Outlet Syndrome Market Snippet by Country
    • 2.1.8. Thoracic Outlet Syndrome Market Snippet by Region
  • 2.2. Competitive Insights

3. Thoracic Outlet Syndrome Key Market Trends

  • 3.1. Thoracic Outlet Syndrome Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Thoracic Outlet Syndrome Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Thoracic Outlet Syndrome Market Opportunities
  • 3.4. Thoracic Outlet Syndrome Market Future Trends

4. Thoracic Outlet Syndrome Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Thoracic Outlet Syndrome Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Thoracic Outlet Syndrome Market Landscape

  • 6.1. Thoracic Outlet Syndrome Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Thoracic Outlet Syndrome Market - By Route of Administration

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 7.1.2. Parenteral
    • 7.1.3. Oral
    • 7.1.4. Others

8. Thoracic Outlet Syndrome Market - By Technology/Mode of Action

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology/Mode of Action, 2024 & 2032 (%)
    • 8.1.2. Nerve & Vascular Decompression Tools
    • 8.1.3. Physical Rehabilitation & Manual Therapy Techniques
    • 8.1.4. Minimally Invasive Surgical Technologies
    • 8.1.5. Pharmacological Pain Management
    • 8.1.6. Imaging & Diagnostic Modalities

9. Thoracic Outlet Syndrome Market - By Drug Class

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 9.1.2. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • 9.1.3. Anticoagulants
    • 9.1.4. Corticosteroids
    • 9.1.5. Muscle Relaxants
    • 9.1.6. Thrombolytics
    • 9.1.7. Others

10. Thoracic Outlet Syndrome Market - By Product Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 10.1.2. Physical Therapy & Rehabilitation Solutions
      • 10.1.2.1. Nerve-gliding techniques
      • 10.1.2.2. Postural correction programs
    • 10.1.3. Pharmacological Treatments
      • 10.1.3.1. NSAIDs
      • 10.1.3.2. Neuropathic pain medications
      • 10.1.3.3. Muscle relaxants
    • 10.1.4. Diagnostic Imaging & Evaluation Tools
      • 10.1.4.1. Doppler ultrasound systems
      • 10.1.4.2. MRI/CT imaging systems
    • 10.1.5. Surgical Intervention Tools & Devices
      • 10.1.5.1. First rib resection tools
      • 10.1.5.2. Scalenectomy instruments
    • 10.1.6. Supportive & Adjunctive Treatment Devices
      • 10.1.6.1. Pain management devices
      • 10.1.6.2. Orthotic braces

11. Thoracic Outlet Syndrome Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 11.1.2. Arterial Thoracic Outlet Syndrome
    • 11.1.3. Venous Thoracic Outlet Syndrome
    • 11.1.4. Neurogenic Thoracic Outlet Syndrome
    • 11.1.5. Mixed/Non-specified TOS Conditions

12. Thoracic Outlet Syndrome Market - By End-User

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 12.1.2. Hospitals & Specialty Care Centers
    • 12.1.3. Physiotherapy & Rehabilitation Clinics
    • 12.1.4. Outpatient Surgical Centers
    • 12.1.5. Diagnostic Imaging Centers
    • 12.1.6. Other End-Users

13. Thoracic Outlet Syndrome Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Thoracic Outlet Syndrome Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.2.10. U.S.
      • 13.2.10.1. Overview
      • 13.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.10.3. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.2.10.4. U.S. Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.2.10.5. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.2.10.6. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.2.10.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.10.8. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.2.11. Canada
      • 13.2.11.1. Overview
      • 13.2.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.2.11.3. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.2.11.4. Canada Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.2.11.5. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.2.11.6. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.2.11.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.2.11.8. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Thoracic Outlet Syndrome Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.10. Germany
      • 13.3.10.1. Overview
      • 13.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.10.3. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.10.4. Germany Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.10.5. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.10.6. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.10.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.10.8. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.11. UK
      • 13.3.11.1. Overview
      • 13.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.11.3. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.11.4. UK Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.11.5. UK Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.11.6. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.11.7. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.11.8. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.12. France
      • 13.3.12.1. Overview
      • 13.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.12.3. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.12.4. France Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.12.5. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.12.6. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.12.8. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.13. Italy
      • 13.3.13.1. Overview
      • 13.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.13.3. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.13.4. Italy Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.13.5. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.13.6. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.13.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.13.8. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.14. Spain
      • 13.3.14.1. Overview
      • 13.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.14.3. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.14.4. Spain Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.14.5. Spain Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.14.6. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.14.7. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.14.8. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.15. The Netherlands
      • 13.3.15.1. Overview
      • 13.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.15.3. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.15.4. The Netherlands Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.15.5. The Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.15.6. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.15.7. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.15.8. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.16. Sweden
      • 13.3.16.1. Overview
      • 13.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.16.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.16.4. Sweden Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.16.5. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.16.6. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.16.7. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.16.8. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.17. Russia
      • 13.3.17.1. Overview
      • 13.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.17.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.17.4. Russia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.17.5. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.17.6. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.17.7. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.17.8. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.18. Poland
      • 13.3.18.1. Overview
      • 13.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.18.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.18.4. Poland Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.18.5. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.18.6. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.18.7. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.18.8. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.3.19. Rest of Europe
      • 13.3.19.1. Overview
      • 13.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.3.19.3. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.3.19.4. Rest of the Europe Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.3.19.5. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.3.19.6. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.3.19.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.3.19.8. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Thoracic Outlet Syndrome Key Manufacturers in Asia Pacific
    • 13.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.4.4. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.4.5. APAC Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.4.6. APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.4.7. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.4.8. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.4.9. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.10. China
      • 13.4.10.1. Overview
      • 13.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.10.3. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.10.4. China Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.10.5. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.10.6. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.10.8. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.11. India
      • 13.4.11.1. Overview
      • 13.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.11.3. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.11.4. India Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.11.5. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.11.6. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.11.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.11.8. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.12. Japan
      • 13.4.12.1. Overview
      • 13.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.12.3. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.12.4. Japan Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.12.5. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.12.6. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.12.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.12.8. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.13. South Korea
      • 13.4.13.1. Overview
      • 13.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.13.3. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.13.4. South Korea Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.13.5. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.13.6. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.13.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.13.8. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.14. Australia
      • 13.4.14.1. Overview
      • 13.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.14.3. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.14.4. Australia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.14.5. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.14.6. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.14.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.14.8. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.15. Indonesia
      • 13.4.15.1. Overview
      • 13.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.15.3. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.15.4. Indonesia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.15.5. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.15.6. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.15.8. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.16. Thailand
      • 13.4.16.1. Overview
      • 13.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.16.3. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.16.4. Thailand Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.16.5. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.16.6. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.16.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.16.8. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.17. Philippines
      • 13.4.17.1. Overview
      • 13.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.17.3. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.17.4. Philippines Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.17.5. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.17.6. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.17.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.17.8. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.4.18. Rest of APAC
      • 13.4.18.1. Overview
      • 13.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.4.18.3. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.4.18.4. Rest of APAC Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.4.18.5. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.4.18.6. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.4.18.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.4.18.8. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.5. Latin America (LATAM)
    • 13.5.1. Overview
    • 13.5.2. Thoracic Outlet Syndrome Key Manufacturers in Latin America
    • 13.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.5.4. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.5.5. LATAM Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.5.6. LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.5.7. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.5.8. LATAM Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.5.9. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.10. Brazil
      • 13.5.10.1. Overview
      • 13.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.10.3. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.10.4. Brazil Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.10.5. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.10.6. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.10.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.10.8. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.11. Mexico
      • 13.5.11.1. Overview
      • 13.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.11.3. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.11.4. Mexico Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.11.5. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.11.6. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.11.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.11.8. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.12. Argentina
      • 13.5.12.1. Overview
      • 13.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.12.3. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.12.4. Argentina Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.12.5. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.12.6. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.12.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.12.8. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.13. Colombia
      • 13.5.13.1. Overview
      • 13.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.13.3. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.13.4. Colombia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.13.5. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.13.6. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.13.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.13.8. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.5.14. Rest of LATAM
      • 13.5.14.1. Overview
      • 13.5.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.5.14.3. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.5.14.4. Rest of LATAM Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.5.14.5. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.5.14.6. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.5.14.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.5.14.8. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 13.6. Middle East and Africa
    • 13.6.1. Overview
    • 13.6.2. Thoracic Outlet Syndrome Key Manufacturers in Middle East and Africa
    • 13.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 13.6.4. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 13.6.5. Middle East and Africa Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
    • 13.6.6. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 13.6.7. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 13.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 13.6.9. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.10. Saudi Arabia
      • 13.6.10.1. Overview
      • 13.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.10.3. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.10.4. Saudi Arabia Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.10.5. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.10.6. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.10.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.10.8. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.11. United Arab Emirates
      • 13.6.11.1. Overview
      • 13.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.11.3. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.11.4. United Arab Emirates Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.11.5. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.11.6. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.11.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.11.8. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.12. Israel
      • 13.6.12.1. Overview
      • 13.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.12.3. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.12.4. Israel Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.12.5. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.12.6. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.12.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.12.8. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.13. Turkey
      • 13.6.13.1. Overview
      • 13.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.13.3. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.13.4. Turkey Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.13.5. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.13.6. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.13.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.13.8. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.14. Algeria
      • 13.6.14.1. Overview
      • 13.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.14.3. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.14.4. Algeria Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.14.5. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.14.6. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.14.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.14.8. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.15. Egypt
      • 13.6.15.1. Overview
      • 13.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.15.3. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.15.4. Egypt Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.15.5. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.15.6. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.15.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.15.8. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 13.6.16. Rest of MEA
      • 13.6.16.1. Overview
      • 13.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 13.6.16.3. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 13.6.16.4. Rest of MEA Market Size and Forecast, By Technology/Mode of Action, 2019 - 2032 (US$ Million)
      • 13.6.16.5. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 13.6.16.6. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 13.6.16.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 13.6.16.8. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

14. Key Vendor Analysis- Thoracic Outlet Syndrome Industry

  • 14.1. Competitive Benchmarking
    • 14.1.1. Competitive Dashboard
    • 14.1.2. Competitive Positioning
  • 14.2. Company Profiles
    • 14.2.1. Stryker
    • 14.2.2. Globus Medical
    • 14.2.3. Becton Dickinson (BD)
    • 14.2.4. Smith and Nephew
    • 14.2.5. Hologi
    • 14.2.6. Zimmer Biomet
    • 14.2.7. Cook Medical
    • 14.2.8. Abbott
    • 14.2.9. B. Braun
    • 14.2.10. Teleflex
    • 14.2.11. Philips Healthcare
    • 14.2.12. Terumo Corporation
    • 14.2.13. Medtronic
    • 14.2.14. Cardinal Health
    • 14.2.15. Boston Scientific
    • 14.2.16. CONMED Corporation
    • 14.2.17. Johnson & Johnson (DePuy Synthes)
    • 14.2.18. Siemens Healthineers
    • 14.2.19. GE HealthCare
    • 14.2.20. Koninklijke Philips
    • 14.2.21. NuVasive
    • 14.2.22. Arthrex
    • 14.2.23. AngioDynamics
    • 14.2.24. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us